TrialCancer medicine2020

Phase II trial of S-1 treatment as palliative-intent chemotherapy for previously treated advanced thymic carcinoma.

Yusuke Okuma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.